---
figid: PMC9369249__ijms-23-08806-g008
pmcid: PMC9369249
image_filename: ijms-23-08806-g008.jpg
figure_link: /pmc/articles/PMC9369249/figure/ijms-23-08806-f008/
number: Figure 8
figure_title: ''
caption: 'Dexmedetomidine attenuates activation of NLRP3 inflammasome in BV2 cells.
  BV2 cells were untreated or stimulated with LPS or LPS + ATP or Dex (n = 7~8 per
  group). (A) Immunoprecipitation analysis of the NLRP3 inflammasome interacting components.
  NLRP3, ASC, and Caspase-1. (B) IL-1Î² release in conditioned medium was measured,
  *, p < 0.05 compared to the con; #, p < 0.05 compared to the Dex 0.'
article_title: Neuroprotective Effect of Dexmedetomidine against Postoperative Cognitive
  Decline via NLRP3 Inflammasome Signaling Pathway.
citation: Inja Cho, et al. Int J Mol Sci. 2022 Aug;23(15):8806.
year: '2022'

doi: 10.3390/ijms23158806
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- antioxidant
- dexmedetomidine
- inflammation
- NLRP3 inflammasome
- reactive oxygen species
- postoperative cognitive dysfunction

---
